Also trades as: BSX-PA (NYSE) · $vol 22M · 0HOY.L (LSE) · $vol 2M · BSX.F (FSX) · $vol 0M

$57.78

+0.63 (+1.10%)

Weekly Expected Move ±7.1%

$45 $49 $53 $56 $60

NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 53 · $85.9B mcap · 1.48B float · 1.12% daily turnover · Short 29% of daily vol

Revenue

$20.1B +19.9% ▲

5Y CAGR: +15.2%

Gross Profit

$13.9B +34.9% ▲

5Y CAGR: +20.0%

Operating Income

$4.0B +50.7% ▲

5Y CAGR: +45.9%

Net Income

$2.9B +55.7% ▲

EPS (Diluted)

$1.94 +55.2% ▲

EBITDA

$3.7B -5.2% ▼

5Y CAGR: +19.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$11.9B	$12.7B	$14.2B	$16.7B	$20.1B
YoY Growth	+19.9%	+6.7%	+12.3%	+17.6%	+19.9%
Cost of Revenue	$4.4B	$5.0B	$5.4B	$6.5B	$6.2B
Gross Profit	$7.5B	$7.7B	$8.8B	$10.3B	$13.9B
Gross Margin	62.8%	60.8%	62.0%	61.3%	69.0%
R&D Expenses	$1.2B	$1.3B	$1.4B	$1.6B	$2.1B
SG&A Expenses	$4.3B	$4.5B	$5.2B	$6.0B	$6.9B
Operating Expenses	$5.5B	$5.9B	$6.7B	$7.6B	$9.9B
Operating Income	$1.9B	$1.8B	$2.2B	$2.6B	$4.0B
Operating Margin	16.2%	14.4%	15.3%	15.7%	19.8%
Interest Expense	$349M	$464M	$272M	$387M	$349M
Income Before Tax	$1.1B	$1.1B	$2.0B	$2.3B	$3.4B
Tax Expense	$36M	$443M	$393M	$436M	$493M
Net Income	$1.0B	$698M	$1.6B	$1.9B	$2.9B
Net Margin	8.7%	5.5%	11.2%	11.1%	14.4%
EPS (Diluted)	$0.69	$0.45	$1.07	$1.25	$1.94
EBITDA	$2.5B	$2.7B	$3.5B	$3.9B	$3.7B
Shares Outstanding	1.43B	1.44B	1.46B	1.49B	1.49B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$4.1B	$4.2B	$4.6B	$4.7B	$5.1B	$5.1B	$5.3B	$5.2B
Cost of Revenue	$1.5B	$1.6B	$1.9B	$1.7B	$1.6B	$1.5B	$1.3B	$1.6B
Gross Profit	$2.6B	$2.6B	$2.7B	$3.0B	$3.4B	$3.5B	$3.9B	$3.6B
Gross Margin	62.7%	62.9%	58.6%	63.3%	67.7%	69.9%	74.5%	69.4%
R&D Expenses	$383M	$407M	$460M	$443M	$526M	$514M	$569M	$516M
SG&A Expenses	$1.4B	$1.6B	$1.6B	$1.6B	$1.7B	$1.7B	$1.8B	$1.8B
Operating Expenses	$1.8B	$2.0B	$2.1B	$2.1B	$2.6B	$2.5B	$2.7B	$2.5B
Operating Income	$747M	$674M	$589M	$896M	$819M	$1.1B	$1.2B	$1.1B
Operating Margin	18.1%	16.0%	12.9%	19.2%	16.2%	20.7%	22.8%	20.6%
Interest Expense	$81M	$83M	$139M	$87M	$90M	$87M	$90M	$90M
Income Before Tax	$420M	$668M	$585M	$805M	$941M	$939M	$700M	$1.2B
Tax Expense	$98M	$200M	$23M	$133M	$146M	$183M	$31M	-$176M
Net Income	$324M	$469M	$566M	$674M	$793M	$755M	$668M	$1.3B
Net Margin	7.9%	11.1%	12.4%	14.5%	15.7%	14.9%	12.6%	25.7%
EPS (Diluted)	$0.22	$0.32	$0.38	$0.45	$0.53	$0.50	$0.45	$0.90
EBITDA	$812M	$1.1B	$1.1B	$1.2B	$1.4B	$1.4B	$956M	$1.1B
Shares Outstanding	1.48B	1.49B	1.49B	1.49B	1.49B	1.50B	1.50B	1.50B

BSX NYSE